Peer Review reports
From: FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway
| Original Submission | ||
|---|---|---|
| 1 Aug 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| 29 Sep 2022 | Reviewed | Reviewer Report |
| 10 Oct 2022 | Reviewed | Reviewer Report |
| 30 Oct 2022 | Author responded | Author comments - Xiaojuan Wu |
| Resubmission - Version 5 | ||
| 30 Oct 2022 | Submitted | Manuscript version 5 |
| 14 Nov 2022 | Author responded | Author comments - Xiaojuan Wu |
| Resubmission - Version 6 | ||
| 14 Nov 2022 | Submitted | Manuscript version 6 |
| 17 Nov 2022 | Author responded | Author comments - Xiaojuan Wu |
| Resubmission - Version 7 | ||
| 17 Nov 2022 | Submitted | Manuscript version 7 |
| 21 Nov 2022 | Author responded | Author comments - Xiaojuan Wu |
| Resubmission - Version 8 | ||
| 21 Nov 2022 | Submitted | Manuscript version 8 |
| 25 Nov 2022 | Author responded | Author comments - Xiaojuan Wu |
| Resubmission - Version 9 | ||
| 25 Nov 2022 | Submitted | Manuscript version 9 |
| 29 Nov 2022 | Author responded | Author comments - Xiaojuan Wu |
| Resubmission - Version 10 | ||
| 29 Nov 2022 | Submitted | Manuscript version 10 |
| 16 Dec 2022 | Reviewed | Reviewer Report |
| 29 Dec 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 11 | ||
| Submitted | Manuscript version 11 | |
| Publishing | ||
| 30 Dec 2022 | Editorially accepted | |
| 23 Jan 2023 | Article published | 10.1186/s12890-022-02303-5 |
You can find further information about peer review here.